Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Arrhythmogenic right ventricular dysplasia.

Eric L Anderson1

  • 1Naval Air Station Jacksonville, Florida, USA. NavyFamilyDoctor@cs.com

American Family Physician
|May 4, 2006
PubMed
Summary

Arrhythmogenic right ventricular dysplasia (ARVD) is a heart condition where muscle is replaced by fat and scar tissue. It is a leading cause of sudden cardiac death in young athletes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

American Association for Emergency Psychiatry Task Force on Medical Clearance of Adult Psychiatric Patients. Part II: Controversies over Medical Assessment, and Consensus Recommendations.

The western journal of emergency medicine·2017
Same author

American Association for Emergency Psychiatry Task Force on Medical Clearance of Adults Part I: Introduction, Review and Evidence-Based Guidelines.

The western journal of emergency medicine·2017
Same author

The authors reply.

Psychosomatic medicine·2013
Same author

Medical evaluation and triage of the agitated patient: consensus statement of the american association for emergency psychiatry project Beta medical evaluation workgroup.

The western journal of emergency medicine·2012
Same author

A within-subject comparison of propofol and methohexital anesthesia for electroconvulsive therapy.

The journal of ECT·2012
Same author

ECT in pregnancy: a review of the literature from 1941 to 2007.

Psychosomatic medicine·2008

Area of Science:

  • Cardiology
  • Genetics
  • Pathology

Background:

  • Arrhythmogenic right ventricular dysplasia (ARVD) is a myocardial disease characterized by fibrofatty replacement of normal heart tissue.
  • It is a significant cause of sudden cardiac death, particularly in young individuals and athletes.
  • The condition primarily affects the right ventricle but can involve other cardiac chambers.

Purpose of the Study:

  • To provide a comprehensive overview of arrhythmogenic right ventricular dysplasia.
  • To discuss diagnostic criteria, imaging modalities, and therapeutic strategies for ARVD.
  • To highlight the importance of early diagnosis and management in preventing sudden cardiac death.

Main Methods:

  • Diagnosis relies on established major and minor criteria.
  • Noninvasive imaging includes echocardiography and cardiac magnetic resonance imaging (MRI).
  • Invasive methods involve ventricular angiography and endomyocardial biopsy for confirmation.

Main Results:

  • ARVD is a primary cause of sudden cardiac death in individuals under 35, second only to hypertrophic cardiomyopathy.
  • Patients often present with chest pain, palpitations, or syncope, with sudden death being the initial manifestation in some.
  • The prevalence is estimated at approximately six per 10,000 in specific populations.

Conclusions:

  • Early diagnosis of ARVD is crucial for risk stratification and management.
  • Treatment involves antiarrhythmic drugs, implantable cardioverter-defibrillators (ICDs), and potentially advanced therapies like ablation or transplantation.
  • Continued research is needed to understand the genetic basis and improve therapeutic outcomes for ARVD.

Related Experiment Videos